Subscribe
Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O’Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

What 2 Know

Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O’Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

Cancer Research Institute is a pioneer in using immunotherapy to treat cancer. This week’s guest, Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, discusses the future of oncology research,…
October 18, 2018
ADVERTISEMENT
DOCSF21

Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O’Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

Cancer Research Institute is a pioneer in using immunotherapy to treat cancer. This week’s guest, Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, discusses the future of oncology research, the upcoming CRI Awards Gala, what it’s like working alongside a Nobel Prize winner, and her love of baking.

 

ADVERTISEMENT
DOCSF21

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network and never miss new Episodes!

Proudly supported by:

HealthXLGet Health
cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.